TD Cowen analyst Dan Brennan lowered the firm’s price target on Illumina to $144 from $200 and keeps an Outperform rating on the shares. The firm said while results have been challenging with the X/25B flow cell ramping, easy comps and improved leadership, the outlook is improving.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ILMN: